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SUMMARY
Currently multiresistant Staphylococcus aureus is one common cause of infections with high rates of morbidity and mortality 
worldwide, which directs scientific endeavors in search for novel antimicrobials. In this study, nine extracts from Bidens pilosa (root, 
stem, flower and leaves) and Annona crassiflora (rind fruit, stem, leaves, seed and pulp) were obtained with ethanol: water (7:3, v/v) 
and their in vitro antibacterial activity evaluated through both the agar diffusion and broth microdilution methods against 60 Oxacillin 
Resistant S. aureus (ORSA) strains and against S. aureus ATCC 6538. The extracts from B. pilosa and A. crassiflora inhibited the growth 
of the ORSA isolates in both methods. Leaves of B. pilosa presented mean of the inhibition zone diameters significantly higher than 
chlorexidine 0.12% against ORSA, and the extracts were more active against S. aureus ATCC (p < 0.05). Parallel, toxicity testing by 
using MTT method and phytochemical screening were assessed, and three extracts (B. pilosa, root and leaf, and A. crassiflora, seed) 
did not evidence toxicity. On the other hand, the cytotoxic concentrations (CC50 and CC90) for other extracts ranged from 2.06 to 10.77 
mg/mL. The presence of variable alkaloids, flavonoids, tannins and saponins was observed, even though there was a total absence of 
anthraquinones. Thus, the extracts from the leaves of B. pilosa revealed good anti-ORSA activity and did not exhibit toxicity.
KEYWORDS: Plant extracts; Products with antimicrobial action; Staphylococcus aureus; ORSA; Toxicity tests; Microbial sensitivity 
tests.
INTRODUCTION
Staphylococcus aureus is found in the human microbiota and may 
become pathogenic under certain conditions. It is a human pathogen 
distinguished by its ability to cause infection in virtually every tissue 
and organ system of the body, leading to serious illnesses24,41. The use 
of methicillin and other synthetic penicillins, such as oxacillin started 
in 1959, and represented a significant step in antistaphylococcal therapy 
worldwide. However, the identification of strains of Methicillin-resistant 
S. aureus (MRSA) was recorded in 1962 (hereafter called Oxacillin-
resistant S. aureus [ORSA]), thus spreading fast around the world in 
subsequent years. From the 1980s, the occurrence of ORSA infections 
increased considerably in several countries, and strains of ORSA have 
assumed increasing importance internationally. In addition, at present, 
besides having established itself as an important hospital pathogen, it is 
now beginning to prevail in the wider community as well, becoming one 
common cause of infections with high rates of morbidity and mortality 
throughout the world3,6,60. 
Resistance can be intrinsic to a bacterium, or acquired through 
mutations or by the incorporation of new genes. The increasing prevalence 
of nosocomial infections caused by ORSA/MRSA during the last two 
decades throughout the world has been associated with the widespread 
occurrence of specific strains of ORSA/MRSA international1. Based on 
the genotyping techniques of electrophoresis in pulsed-field gel (EPFG), 
SCCmec typing and multilocus typing sequence, several pandemic 
MRSA clones were identified, including the Iberian (ST247-SCCmecIA), 
Brazilian (ST239-III), New York/Japan (ST5-II), Pediatric (ST5-IV), 
EMRSA-16 (ST36-II), EMRSA-15 (ST22-IV), and Berlin (ST45-IV) 
clones1,19,35. Studies from Brazil showed the predominance of BEC, a 
multi-resistant clone first described in Brazil, in 1992, which accounted 
for 70-80% of total isolates of ORSA/MRSA in Brazilian hospitals20,58. 
Dissemination of ORSA strains is one of the major health issues faced 
by a great number of countries and the phenomenon of the multiresistance is 
becoming alarming. Until today, it has been observed there are an increasing 
number of studies related to the epidemiology of this microorganism in 
centers or in intensive care units which include immunocompromised 
patients who have undergone surgical intervention, who have been 
transplanted or who are suffering from severe burns highlighting the 
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need for the development of drugs that are effective in treating these 
infections6,33,39. To overcome the problem of the multiresistance of the 
microorganisms, scientific efforts have been made. Nevertheless, for 
implementation in medical particle, little has been achieved.
The study of antimicrobial agents on plants has great importance 
and is crucial in several sectors of pharmaceutical sciences and 
cosmetics. Furthermore, plants are strong candidates in studies of bio-
prospecting and the use of data from such studies as a first step to the 
discovery of the pharmacological activity for new antimicrobial agents 
is extremely important, especially in a country like Brazil that offers 
a huge biodiversity to be analyzed, but only a few of these have been 
scientifically investigated5,31,32,37. 
Bidens pilosa Linné (family Asteraceae), commonly called “picão-
preto” is a medicinal plant native to South America that nowadays is 
distributed all over the world, mainly in tropical and subtropical regions16. 
It is a small erect annual herb growing up to 1.5 m high. Considered as 
a weed in many places, it has bright green leaves with serrated prickly 
edges and produces small yellow flowers42. This plant is widely used 
either in traditional medicine or folk medicine by indigenous people to 
treat a variety of illnesses including pain, fever, angina, diabetes, edema 
(water retention), infections, inflammation, anti-flu and in gastroenteritis 
treatment10,29. Extensive researches over the past decades have shown that 
B. pilosa has activities: antiviral11, antifungal18,40 and antibacterial23,28,48. 
Some classes of compounds, such as flavonoids and polyacetylenes, 
were isolated from the B. pilosa and are generally associated in the 
pharmacological activities of this plant16,22,44,51.
Annona crassiflora Mart., 1841, popularly known as “Araticum” or 
“marolo” or “field araticum”, is a member of the Annonaceae family found 
in the Brazilian Cerrado, with socio-economic and medicinal importance. 
The traditional use of this plant includes the treatment of wounds, 
venereal diseases, snakebites, louses and, furthermore, it can act as an 
antimicrobial, antidiarrheal and antirheumatic61. SANTOS et al.50 isolated 
and determined the structure of a new acetogeninase, a prototype substance 
from the ethanol extract seeds, which was named crassiflorina or araticulin. 
There have been many studies done to elucidate the biological actions of 
acetogeninases: RUPPRECHET et al.49 and ZAFRA-POLO et al.64 relate 
them to cytotoxic, antimitotic, antimicrobial and antimalarial; MORRE et 
al.38 and OBERLIES et al.43 reported antitumor activity in in vitro and in 
vivo with different strains of cancer cells, and some acetogeninases were 
effective in the inactivation of multiresistant cell strains to certain drugs 
without causing toxicity in other human cells.
Because of an increase in the microbial resistance to antimicrobials 
available, as well as the limited therapeutic alternatives, there is a need 
to search for novel substances with antimicrobial activity. In this context, 
this study had as its aim to evaluate the in vitro antibacterial activity of 
hydroethanolic extracts from medicinal plants found in the Cerrado of 
Minas Gerais State (Bidens pilosa Linné and Annona crassiflora Mart.) 
against ORSA strains, isolates from the environmental sources (dental 
clinic) previously characterized and genotyped, besides the evaluation 
of the resistant profile of the strains to antibiotics utilized in medical 
particles. In addition, the toxicity and phytochemistry profile of the 
extracts were assessed. 
MATERIALS AND METHODS
Obtaining the ORSA samples: A total of 60 ORSA samples (n = 60) 
from an aerial environment have been isolated at the Integrated Dental 
Clinic, characterized and maintained at the Research Laboratory of 
Genetics and Molecular Biology, both at the University José do Rosário 
Vellano in Alfenas-MG. These samples obtained were collected using 
Petri plates (90 mm ± 15 mm) containing 20 mL of Mannitol salt agar 
(Merck), exposed for two hours during two shifts, from two hours after 
the beginning of each shift, and strategically placed in Dental Clinics. 
The identity of Staphylococcus aureus species was obtained using the 
classical microbiology methods. Additionally, a confirmatory test was 
carried out to evaluate the resistance to oxacillin, suggestive of the mecA 
gene presence by screening the Mueller-Hinton Agar supplemented 
culture with 684 mM NaCl (4% w/v) and oxacillin (6 µg mL-1) similar 
to the method described previously by NCCLS, current Clinical and 
Laboratory Standards Institute (CLSI) in the document M7-A612, in which 
the standard strain of S. aureus ATCC 25923 oxacillin-susceptible was 
also used to ensure reproducibility and accuracy. These isolates were kept 
in the permanent culture -70 ºC. At the time of analysis when utilized 
against the plant extracts, it was reactivated.
Collecting of the plants: Chart 1 shows the coordinates where the 
samples of B. pilosa and A. crassiflora were collected. After collecting 
the plants used in this work, they were identified, registered and filed 
at the Herbarium of the UALF in the Federal University of Alfenas by 
Prof. Dr. Marcelo Polo.
Preparation of the extracts: The plants’ parts from B. pilosa (root, 
stem and flower) and A. crassiflora (rind fruit, stem, seed, pulp and leaf) 
were cleaned and cut manually, then were mixed at a concentration of 
20% weight/volume of ethyl alcohol 70%. Next, they were macerated 
for seven days and kept in the dark with daily shaking. After maceration, 
they received filtration through “nylon” and again through a paper 
filter. Subsequently, the extracts were subjected to evaporation and 
concentration under the negative pressure of 500 mmHg and 60 oC. They 
were then distributed in five mL bottles, frozen and lyophilized, whereby 
yielding dried crude hidroalcoholic extracts. The powders were stored at 
20 °C and finally, before testing, were solubilized in water. 
Chart 1 
Data of collection places and identification of Bidens pilosa and Annona crassiflora analyzed
Family Specie Collection place Coordinates Collection date Exsicata number
Asteraceae Bidens pilosa Linné Pouso Alegre city, MG 22° 27' 75"S 
 18° 45' 90"W
January, 2011 1745
Annonaceae Annona crassiflora Mart. (1841) Alterosa city, MG 21° 850’ 18"S 
 46° 513’ 06"W
March, 2011 1401
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Screening of antibacterial activity: In vitro microbiological tests 
were performed at the Laboratory of Microbiology and Immunology of 
the Federal University of Alfenas. Firstly, the isolates were inoculated 
in specific Vogel Johnson agar (with potassium tellurite), submitted 
to a confirmation of the S. aureus specie by tests of biochemistry 
screening (tests of catalase, coagulase and DNase) and method of Gram. 
Susceptibility testing to antibiotics was conducted by using a method 
described previously by BAUER and KIRBY4. The antibacterial activity 
of the extracts was evaluated through agar diffusion following the 
document CLSI12 with modifications according to SILVA et al.56 (Fig. 
1). Suspensions of overnight-cultured ORSA isolates were prepared in 
saline solution (0.9% NaCl) with a turbidity corresponding to a 0.5 tube 
of Mac-Farland scale and inoculated on the surface of culture medium 
Mueller-Hinton Agar with the help of swabs. Forty µL of these extracts 
(at a concentration of 100 mg/mL) were placed in wells of four mm 
diameter made in the culture medium. The plates were incubated at 37 
°C for 18 hours. After incubation, the reading of growth inhibition zone 
diameters was performed, by using chlorhexidine solution at 0.12% as 
a positive control, and distilled water as a negative control. The standard 
strain of S. aureus ATCC 6538 susceptible to the oxacillin was also used 
with the aim of making a comparison. 
All extracts were submitted to the minimum inhibitory concentration 
(MIC) by using broth microdilution methodology as proposed in 
document M7A612. This methodology was used to evaluate the 
susceptibility of the 60 ORSA samples. The test was carried out in sterile 
microdilution plates with 96 flat bottomed wells, composed of eight 
series identified from A to H, each one with twelve wells. Firstly, 100 
µL of Mueller Hinton broth medium was dispensed into the wells on a 
microplate. Afterwards the extracts were diluted consecutively into the 
wells of the plate with a concentration ranging from 50 to 0.09 mg/mL. 
The suspensions of overnight-cultured of ORSA isolates were suspended 
in saline solution with the turbidity adjusted. They were then dispensed 
into the wells at a volume of 10 µL per well. The columns 11 and 12 
were reserved as controls. The control of the growth promotion was 
composed of 100 µL broth plus 10 µL of the inoculums, the control of 
sterility was composed of 100 µL of the culture medium, and the control 
of extract was composed of 100 µL of the culture medium plus 100 µL 
of extract. The plates were incubated at 37 ºC for 24 hours. The readings 
were made visually comparing the growth of the microorganisms in the 
wells numbered one to ten with the controls as recognized by CLSI12. 
The lowest concentration that produced a significant inhibition of the 
growth was established as the MIC value.
Cytotoxicity screening - MTT method: The cytotoxicity was 
assessed by using the MTT method (3-(4,5-Dimethylthiazol-2-yl)-2,5-
diphenytetrazoliumbromide). Briefly, in accordance with ARAUJO et 
al.2, in this test, 1x104 cells (derived from Aedes albopictus mosquito 
larvae) were seeded per well in 96-well tissue culture plates containing 
0.1 mL of L-15 medium supplemented with 1% of fetal bovine serum 
and with decreasing dilutions from these extracts (5 to 0.039 mg/mL). 
For cell control, only the medium was added. After incubation, 10 µL 
of MTT was added to the wells and incubated for four hours at room 
temperature, in order to incorporate the MTT for the formation of the 
formazan crystals. Spectrophotometric analysis was performed by using 
a reading at a wavelength of 600 nm. The percentage of cytotoxicity was 
calculated using the formula [(AB) / AX100], where A and B are values 
of optical densities of treated and controlled cells, respectively. So, the 
50% cytotoxic (CC50) and 90% cytotoxic (CC90) concentrations were 
calculated and defined as the concentration of the extract that reduced the 
absorbance of treated cells in 50% and 90% respectively, when compared 
with those of the cell control.
Evaluation of phytochemical profile of the extracts: The qualitative 
analyses of chemical substances of the extracts analyzed were determined 
by colorimetric methods and/or precipitator, according to COSTA13. 
These methodologies were selected to determine the presence of 
alkaloids, anthraquinones, flavonoids, tannins, and saponins
.
Statistical Analysis: The agar diffusion tests were realized in 
triplicate and the results were statistically analyzed using Sisvar Software 
Version 5.3. With the aim of comparing the means, the ANOVA analysis 
followed by SCOTT & KNOTT55 as a post test were performed, and the 
means were statistically different when p < 0.05. 
RESULTS
ORSA samples: All the 60 samples analyzed in this experiment were 
properly confirmed as Oxacillin Resistant Staphylococcus aureus (ORSA) 
through a method recognized for definition of resistance to oxicillin. 
Furthermore, the susceptibility profile of the samples to the different 
groups of antibiotics, commonly used in the clinic, was investigated by an 
antibiogram. In Figure 2 it can be observed its heterogeneous multidrug 
resistance to several classes of the antibiotics analyzed. Resistance to 
vancomycin, Azithromycin, and amoxicillin with clavulanic acid were 
presented for 40, 53.3, and 40% of 60 samples respectively. It was 
observed there was a significant intermediate resistance of the isolated 
to ciprofloxacin and clindamycin.
Screening of antibacterial activity of plant extracts through 
agar diffusion technique: In the reading of the growth inhibition 
zones (IZ) diameters (Table 1), the extracts from the stem and root of 
B. pilosa were inactive, and the extracts from the flower and leaf of B. 
Fig. 1 - Determination of the antimicrobial activity of plant extracts according to the 
methodology of SILVA et al., 2010.
SILVA, J.J.; CERDEIRA, C.D.; CHAVASCO, J.M.; CINTRA, A.B.P.; SILVA, C.B.P.; MENDONÇA, A.N.; ISHIKAWA, T.; BORIOLLO, M.F.G. & CHAVASCO, J.K. - In vitro screening 
antibacterial activity of Bidens pilosa Linné and Annona crassiflora Mart. against Oxacillin Resistant Staphylococcus aureus (ORSA) from the aerial environment at the dental clinic. 
Rev. Inst. Med. Trop. Sao Paulo, 56(4): 333-40, 2014. 
336
pilosa were effective against the 60 samples analyzed with an interval 
of IZ diameters ranging from eight to 23 millimeters (mm). For A. 
crassiflora, extracts from the stems, pulp, rind fruit and leaf were actives 
against ORSA with IZ diameters that ranged from five to 15 mm. It 
was verified for the extracts from the B. pilosa and A. crassiflora there 
were better activities through the agar diffusion method as against S. 
aureus ATCC than on ORSA samples. The extract from the leaf of B. 
pilosa had the highest mean of the inhibition zone (IZ) diameters (17 
mm) against ORSA samples used in the experiment (n = 60), followed 
by extract from the flower of B. pilosa (14 mm) (statistically significant 
with p < 0.05). Moreover, extract from the leaf of B. pilosa was the 
most active against S. aureus ATCC, and on ORSA as well, although 
the mean of the IZ diameters values for this extract on ATCC (26 mm) 
was statistically different from that presented against ORSA (17 mm) 
(p < 0.05). Against ORSA, only extracts from the leaf of B. pilosa 
demonstrated inhibitory activity significantly better than those presented 
for chlorhexidine 0.12% (positive control), which had a mean of the 
IZ diameters values of 15 mm. Otherwise, against standard strain, the 
extracts from the leaf and flower of B. pilosa (26 and 22 mm) and rind 
fruit of A. crassiflora (18 mm) were more active than positive control 
(16 mm) (p < 0.05). In general, when comparing the activities of all 
extracts against S. aureus ATCC and against the isolates of ORSA, the 
overall mean of IZ diameters against ATCC was higher than against 
ORSA, so the extracts were more active against the standard strain than 
on the isolates (p < 0.05). 
Determination of Minimum Inhibitory Concentration (MIC): 
The obtained results of MIC values are shown in Table 1, where the 
extracts from the stem of B. pilosa high MIC values (50 mg/mL) against 
ORSA can be observed. On the other hand, for the extracts from the leaf 
and flower, the inhibition of the ORSA isolates with MIC values of 6.25 
and 12.5 respectively was verified. For the extracts from the leaf and 
flower of B. pilosa, the MIC values were 25 and 1.56 respectively against 
S. aureus ATCC. For A. crassiflora, all extracts presented MIC values 
close to the maximum concentration used (50 mg/mL). The extracts from 
Fig. 2 - Profile of the sensitivity from the 60 samples isolated from aerial environment at the 
dental care clinic to antibiotics commonly utilized for treating S. aureus infections. AMO/ACL: 
amoxicillin with clavulanic acid (30); AZI: Azithromycin (15); CIPRO: Ciprofloxacin (05); 
CLIN: Clindamycin (02); DOX: doxycycline (30); NOR: Norfloxacin (10), OXA: Oxacillin 
(10); VAN: Vancomycin (30); LIN: Linezolid (30). R: Resistant ; S: Sensitive; I: Intermediate. 
Table 1
Interval and mean of the growth inhibition zone (IZ) diameters, MIC values, assessment of toxicity, and qualitative results of the phytochemical analysis of 
hidroethanolics extracts from the Bidens pilosa Linné and Anonna crassiflora Mart
Species Extract
Interval and mean1,2,3 of the 
IZ diameters (mm) MIC (mg/mL)
Assessment of 
toxicity Selectivity Index (SI) Secondary metabolites
ORSA4 S. aureus ATCC 6538 ORSA
S. aureus 
ATCC 6538
CC50 
(mg/mL)
CC90 
(mg/mL) ORSA
S. aureus 
ATCC 6538 Al An Fl Ta Sa
Bidens 
pilosa
Root 0 (0)a 0 (0)a N N NT NT NA NA - - - + +
Stem 0 (0)a 0 (0)a 50 25 3.91 7.27 0.078 0.156 + - - + +
Flower 8 – 20 (14)e 21 -23 (22)i 12.5 1.56 2.82 5.41 0.226 1.808 + - + + +
Leaf 8 -23 (17)g 25 -28 (26)j 6.25 25 NT NT NA NA + - + + +
Anonna 
crassiflora
Rind fruit 6 – 15 (12)d 16 -20 (18)h 50 6. 25 2.06 9.38 0.041 0.330 + - - + -
Stem 5 – 15 (9)b 10 – 14 (12)d 25 1.56 5.86 10.77 0.234 3.756 - - - + -
Seed 0 (0)a 0 (0)a 50 N NT NT NA NA - - - - -
Pulp 6 – 15 (9)b 14 -18 (16)f 25 12.5 2.68 5.98 0.107 0.214 + - - - +
Leaf 6 – 14 (10)c 10 -14 (12)d 25 25 3.86 8.03 0.154 0.154 + - + - -
Controls
Chlorexidine 
0.12
10 – 26 (15)f 15 -18 (16)f NA NA NA NA NA NA NA NA NA NA NA
Distilled 
water
0 (0)a 0 (0)a NA NA NA NA NA NA NA NA NA NA NA
1Between parenthesis; 2means followed by same letter show no statistic difference each other according to Scott & Knott test at 5% of significance (α=0.05); 3All tests 
by agar diffusion with the extracts at a concentration of 100 mg/mL; 4n=60 samples; MIC: Minimum inhibitory concentration; CC50: 50% cytotoxic concentration; 
CC90: 90% cytotoxic concentration; SI= CC50 / MIC; N= absence of inhibition at the maximal concentration used; NT= Non-toxic at the concentrations used; NA = Not 
applicable to this analysis; Al: Alkaloids; An: Anthraquinones; Fl: Flavonoids; Ta: Tannins; Sa: Saponins; + : positive reaction; - : negative reaction.
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the stem of A. crassiflora and flower of B. pilosa presented the lowest 
MIC values against S. aureus ATCC (1.56 mg/mL).
Phytochemical evaluation of plant extracts: The phytochemical 
profiles of the extracts (Table 1) revealed that all extracts from the B. 
pilosa were positive for tannins and saponins, and almost all were positive 
for alkaloids (three in four extracts). For A. crassiflora, the variable 
presence of alkaloids, flavonoids, tannins and saponins was evidenced. 
All extracts (from the B. pilosa and A. crassiflora) were negative for 
anthraquinones.
Evaluation of cytotoxic activity of extracts on cell culture: 
Parallel analysis was held for evaluation of cytotoxicity of the extracts. 
In the examination carried out on cell culture, in accordance with Table 
1, the extracts from the leaf and root of B. pilosa showed no toxicity in 
the concentrations tested on cell culture. On the other hand, the 50% 
cytotoxic concentration (CC50) ranged from 1.30 mg to 9.56 mg/mL 
for all others extracts. The 90% cytotoxic concentration (CC90) ranged 
from 2.55 to 19.00 mg/mL. For A. crassiflora, the CC50 and CC90 ranged 
from 2.06 to 5.86 and from 5.93 to 10.77 respectively. For the extract 
from the seed, it was verified there was no toxicity in the concentration 
tested. According to PROTOPOPOVA et al.47 the selectivity index (SI) is 
calculated as the ratio between the CC50 and the MIC. The values found 
were lower in the analysis against ORSA. For the IS values against the 
standard strain, the most satisfactory was 3.756 for the extract from the 
stem of A. crasssiflora.
DISCUSSION
The ORSA samples analyzed in this experiment are from the 
environment at the dental care clinic (air), where the transmission of 
pathogens is intense due to the instrumentation used, such as high 
speed instruments. These factors make the dental clinical environment 
as prone to cross-contamination and/or cross-transmission for S. 
aureus, as in a hospital environment46,62. It can lead to contamination 
and infection of patients. The profile of the sensitivity (Fig. 1) for the 
ORSA samples analyzed strengthens previous studies, which indicate 
a massive dissemination of the multiresistant S. aureus, in which 
most strains of ORSA exhibit high level resistance to commercially 
available antimicrobial agents. Furthermore, S. aureus remains a major 
cause of nosocomial disease15 and recent reports have indicated that 
the epidemiology of ORSA may be undergoing a change through 
the emergence of community-acquired infections27. Until recently, 
vancomycin has been used to treat ORSA infections, and the failure 
in the treatment with vancomycin and other antimicrobial agents has 
been reported, raising concerns that treatment of ORSA infections has 
become even more problematic and has led to higher rates of morbidity 
and mortality throughout the world1,15,59. Therefore, there is a need to 
search for new therapies. Previous studies have related the importance 
of plants as a source of compounds with antimicrobial activity or provide 
a viable therapeutic strategy as phytomedicines36,48,61,63. 
In this work, the anti-ORSA activity of the extracts from the different 
parts of B. pilosa and A. crassiflora were evaluated through the agar 
diffusion method and broth microdilution. In the evaluation through 
the agar diffusion method, it has shown a ranging interval of the IZ 
diameters for each extract against the 60 ORSA isolates (Table 1). This 
may be at least partly explained as a result of morphophysiological 
differences, derived from the specific genetics of the samples1,3,19,20. 
Despite the reproducibility of the results through the diffusion method 
in the Mueller-Hinton Agar12, nowadays it is known that in the evaluation 
of the antimicrobial activity of plant extracts, which are complex blends, 
through agar diffusion, several factors can influence the IZ diameters 
values and the reproducibility remains controversial45. In addition, 
because of the extracts, depletion or destruction of the compounds of 
the culture medium can occur, inhibiting the microorganisms; therefore, 
perhaps the antimicrobial action did not result from a direct interaction 
between the extracts and the microorganisms.
Regarding the diffusion agar method, there are a large number of 
scientific studies highlighting the antibacterial properties of plants14. 
MATTANA et al.34 observed resistant S. aureus to methicillin highly 
susceptible to ethyl acetate and ethanol extracts of Acacia aroma, through 
the agar diffusion method. It also observed that ethanol extracts showed 
greater antimicrobial activity compared to extracts which had only water 
as a solvent. The extracts used in this study have undergone maceration 
through ethyl alcohol 70% and an excellent antibacterial performance 
by agar diffusion was observed, thus confirming the assertion described 
by MATTANA et al.34, probably due to the alcohol that extracts greater 
numbers of polar and nonpolar substances. Additionally, the difference of 
solubility for each extract can be an influence during the diffusion in agar, 
where extracts with the greatest concentrations of more polar substances 
show better diffusion than those richer in non-polar substances. In our 
study, the extracts were more active against the standard strain of S. 
aureus than against the ORSA isolates, and the extract from the leaf of 
B. pilosa was the most active by agar diffusion (p < 0.05).
In the determination of MIC (Table 1) by using broth microdilution, 
it was found that the extract from the stem of B. pilosa showed MIC 
value of 50 mg/mL and, in this sense, the antibacterial activity of this 
extract should be taken into account with the cytotoxic activity, aiming 
either studies for bioassay-guided fractionation of novel compounds 
or likewise to studies of the quality, effectiveness and safety of herbal 
medicinal preparations63. 
The extracts from the leaf and flower of B. pilosa showed inhibition 
results at lower concentrations. FABRI et al.21 reported the antimicrobial 
activity of members of the family Asteraceae, to which B. pilosa belongs. 
Despite the extracts from the stem of B. pilosa and the seed of A. 
crassiflora at a concentration of 100 mg/mL no evidenced antibacterial 
activity through the agar diffusion method was observed; MIC values of 
50 mg/mL were verified, in both cases. In accordance with HADECEK 
& GREGER25, it is acknowledged that the broth microdilution presents 
higher sensitivity than the agar diffusion method, by allowing direct 
contact between the compound, the medium and the microorganisms, so 
that the inactivity of the extracts through the agar diffusion parallel the 
activity by broth microdilution, probably occurring due to this. 
MATTANA et al.34 related the activity of organic extracts of Acacia 
aroma against ORSA with MICs that ranged from 2.5 to 10 mg/mL. 
The MIC values for Hyptis martiusii on MRSA and MSSA (methicillin 
sensitive S. aureus) developed by COUTINHO et al.14 ranged from 128 
to ≥ 1024 mg/mL, values greater than that found in our study. Analyzing 
the results of MIC in Table 1, in general, the extracts evaluated showed 
higher MIC values against ORSA when compared with the values found 
against the standard strain sensitive to oxacillin S. aureus. Only the extract 
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from the leaf of B. pilosa had low MIC values on ORSA (6.25 mg/mL) 
when comparing those presented against a standard strain (25 mg/mL). 
As for the phytochemical profile, it was observed that, among 
extracts, there was a total absence of anthraquinones and the variable 
presence of alkaloids, flavonoids, tannins, and saponins. It confirms 
previous studies in which such compounds are commonly isolated from 
these plants7,8,30. 
A. crassiflora extracts showed the presence of alkaloids in rind fruit, 
pulp and leaf extracts. In 1982, LEBOEUF et al.30 published a review 
about the Annonaceae phytochemical family, where the predominance 
of aporphine and oxoaporphine alkaloids among secondary metabolites 
isolated from species belonging to the family was reported. It was 
observed that the extracts from the stem and fruit bark presented 
tannins. Saponins were observed only in the pulp extract and flavonoids 
only in leaf extract. Besides alkaloids, constituents like polyphenols, 
essential oils, terpenes and aromatic substances are also found in family 
representatives30. Regarding the phenolic compounds in the Annonaceae 
family the most frequent ones are flavonoids57.
Analysis of B. pilosa revealed that the majority of the extracts showed 
positive for alkaloids, flavonoids, tannins and saponins. This result 
confirms previous studies which state that the main compounds already 
isolated from the plant are poliacetylenic and flavonoid substances8. 
BORGES7 also determined the presence of phenolic compounds such 
as tannins and flavonoids, and also showed positive results for saponins 
and alkaloids, which are results observed in this study. In addition, 
researches have reported that alkaloids, flavonoids, tannins and saponins 
are implicated in the antimicrobial action9,17,53,54. So, the activity found in 
our study for the plants evaluated could be associated with the presence 
of these compounds26. 
Concerning the inactivity or antimicrobial activity of the extracts 
and the presence of metabolites mentioned, the complexity of plant 
extracts should not be overlooked, being the final response (antibacterial 
activity) result of synergistic, antagonistic and other interactive effects 
among their bioactive components61. Previous studies have reported the 
antimicrobial activity for the metabolite isolated, and in the case of the 
study with crude extracts, interactions between the compounds must be 
considered possible. Notwithstanding this, the antimicrobial activity 
presented could be mediated at least partly by the compounds from the 
extracts, which could affect the morphophysiology of the microorganism. 
With the results of the assessment of toxicity (Table 1), it can be 
observed that extract from the leaf of B. pilosa showed a desirable 
characteristic among the extracts because it showed no toxic at the 
concentration utilized, besides presenting a lower MIC (6.25 mg/mL) 
against ORSA, with a good chance of application in further studies by 
bio-prospection. The extract from the stem of A. crassiflora proved to be 
the more toxic. As to the selectivity, extract from the stem of A. crassiflora 
showed the better selectivity index (SI) against ORSA (0.234), and on 
standard strain (3.756). 
In summary, the extracts from the flower and leaf of Bidens pilosa; 
and rind fruit, pulp, stem and leaf of A. crassiflora inhibited the growth of 
the ORSA isolates by both methods tested; however, extracts from the root 
of B. pilosa and seed of A. crassiflora displayed no antimicrobial activity. 
As for the toxicity, some extracts did not show toxicity. Therefore, a good 
extract due to the fact that it showed lower MIC and no toxic effect was 
the extract from the leaf of B. pilosa. Further studies must be realized, in 
order to identify and isolate compounds responsible for this activity and 
understand how they exercise this effect on the Staphylococcus species. 
RESUMO
Triagem in vitro da atividade antibacteriana de Bidens pilosa 
Linné e Annona crassiflora Mart. contra Staphylococcus aureus 
resistente à oxacilina (ORSA) provenientes do ambiente aéreo na 
clínica odontológica 
Atualmente Staphylococcus aureus multirresistente é causa comum 
de infecções com altas taxas de morbidade e mortalidade mundialmente, 
o que direciona esforços científicos na busca de novos antimicrobianos. 
Neste estudo, nove extratos de Bidens pilosa (raiz, caule, flor e folhas) 
e de Annona crassiflora (casca do fruto, caule, folha, semente e polpa) 
foram obtidos com etanol:água (7:3, v/v) e suas atividades antibacteriana 
in vitro avaliadas através de difusão em agar e microdiluição em caldo 
contra 60 cepas de Oxacillin Resistant S. aureus (ORSA) e contra S. 
aureus ATCC 6538. Os extratos de B. pilosa e A. crassiflora inibiram 
o crescimento dos isolados ORSA em ambos os métodos. O extrato da 
folha de B. pilosa apresentou média dos diâmetros dos halos de inibição 
significativamente maior que a clorexidina 0,12%, contra os isolados 
ORSA, e os extratos foram mais ativos contra S. aureus ATCC (p < 
0,05). Paralelamente, teste de toxicidade pelo método MTT e triagem 
fitoquímica foram avaliadas, e três extratos (raiz e folha de B. pilosa 
e semente de A. crassiflora) não apresentaram toxicidade. Por outro 
lado, as concentrações citotóxicas (CC50 e CC90) para os outros extratos 
variaram de 2,06 a 10,77 mg/mL. Observou-se variável presença de 
alcalóides, flavonóides, taninos e saponinas, apesar de total ausência de 
antraquinonas. Portanto, os extratos das folhas de B. pilosa revelaram 
boa atividade anti-ORSA e não exibiram toxicidade.
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